| Contributors |
|
vii | |
| Preface |
|
xv | |
| How to use this book |
|
xxiii | |
| Side effects monographs |
|
xxv | |
| Introduction: What are we doing in medicines safety? |
|
xxvii | |
| A perspective from the Uppsala Monitoring Centre |
|
|
|
|
Central nervous system stimulants and drugs that alter appetite |
|
|
1 | (32) |
|
|
|
|
|
|
|
33 | (53) |
|
|
|
|
|
|
|
86 | (9) |
|
|
|
|
|
95 | (26) |
|
|
|
Hypnosedatives and anxiolytics |
|
|
121 | (18) |
|
|
|
Neuroleptic and antipsychotic drugs |
|
|
139 | (25) |
|
|
|
|
|
|
|
|
|
164 | (34) |
|
|
|
|
|
|
|
Opioid analgesics and antagonists |
|
|
198 | (33) |
|
|
|
|
|
231 | (15) |
|
|
|
Non-steroidal anti-inflammatory drugs |
|
|
246 | (64) |
|
|
|
|
|
310 | (5) |
|
|
|
General anesthetics and anesthetic gases |
|
|
315 | (24) |
|
|
|
|
|
339 | (18) |
|
|
|
|
|
Neuromuscular blocking agents and skeletal muscle relaxants |
|
|
357 | (56) |
|
|
|
|
|
Drugs affecting autonomic functions or the extrapyramidal system |
|
|
413 | (34) |
|
|
|
|
|
Dermatological drugs, topical agents and cosmetics |
|
|
447 | (34) |
|
|
|
Antihistamines (H1-receptor antagonists) |
|
|
481 | (11) |
|
|
|
Drugs acting on the respiratory tract |
|
|
492 | (31) |
|
|
|
Positive inotropic drugs and drugs used in dysrhythmias |
|
|
523 | (52) |
|
|
|
Antianginal drugs and (β-adrenoceptor antagonists |
|
|
575 | (54) |
|
|
|
|
|
Drugs acting on the cerebral and peripheral circulations and drugs used in the treatment of migraine |
|
|
629 | (9) |
|
|
|
|
|
638 | (18) |
|
|
|
|
|
656 | (27) |
|
|
|
|
|
683 | (31) |
|
|
|
|
|
|
|
714 | (40) |
|
|
|
|
|
Antiseptic drugs and disinfectants |
|
|
754 | (31) |
|
|
|
β-Lactam antibiotics: immunological reactions and microbiological resistance |
|
|
785 | (6) |
|
|
|
|
|
|
|
Reactions typically shared by more than one class of β-lactam antibiotics |
|
|
791 | (19) |
|
|
|
|
|
|
|
|
|
|
|
810 | (11) |
|
|
|
|
|
|
|
|
|
β-Lactams: cephalosporins |
|
|
821 | (9) |
|
|
|
|
|
|
|
|
|
β-Lactams: carbapenems, monobactams, and beta-lactamase inhibitors |
|
|
830 | (7) |
|
|
|
|
|
|
|
|
|
Miscellaneous antibacterial drugs: aminoglycosides, chloramphenicol and thiamphenicol, fluoroquinolones, glycopeptides |
|
|
837 | (34) |
|
|
|
|
|
Miscellaneous antibacterial drugs: lincomycins, macrolides, nitrofurantoin, polymyxins |
|
|
871 | (25) |
|
|
|
|
|
Miscellaneous antibacterial drugs: sulfonamides and trimethoprim, tetracyclines, other antimicrobial drugs |
|
|
896 | (26) |
|
|
|
|
|
922 | (25) |
|
|
|
|
|
|
|
947 | (42) |
|
|
|
|
|
989 | (16) |
|
|
|
Drugs used in tuberculosis and leprosy |
|
|
1005 | (25) |
|
|
|
|
|
|
|
1030 | (17) |
|
|
|
|
|
1047 | (64) |
|
|
|
Blood, blood components, plasma and plasma products |
|
|
1111 | (29) |
|
|
|
Intravenous infusions - solutions and emulsions |
|
|
1140 | (31) |
|
|
|
Drugs affecting blood clotting, fibrinolysis and hemostasis |
|
|
1171 | (37) |
|
|
|
|
|
|
|
1208 | (12) |
|
|
|
|
|
1220 | (26) |
|
|
|
Drugs acting on the immune system |
|
|
1246 | (92) |
|
|
|
|
|
|
|
|
|
1338 | (26) |
|
|
|
Corticotrophins and corticosteroids |
|
|
1364 | (32) |
|
|
|
|
|
1396 | (9) |
|
|
|
|
|
|
|
1405 | (43) |
|
|
|
|
|
1448 | (37) |
|
|
|
Thyroid and antithyroid drugs |
|
|
1485 | (16) |
|
|
|
Insulin, glucagon and hypoglycemic drugs |
|
|
1501 | (19) |
|
|
|
|
|
1520 | (7) |
|
|
|
Drugs affecting lipid metabolism |
|
|
1527 | (11) |
|
|
|
Cytastatics and immunosuppressive drugs |
|
|
1538 | (58) |
|
|
|
Radiological contrast media |
|
|
1596 | (35) |
|
|
|
|
|
1631 | (5) |
|
|
|
|
|
Drugs used in ocular treatment |
|
|
1636 | (13) |
|
|
|
Risks associated with complementary therapies |
|
|
1649 | (33) |
|
|
|
Miscellaneous drugs and materials |
|
|
1682 | (39) |
|
|
| Address list of National Centers participating in the WHO Drug Monitoring scheme |
|
1721 | (10) |
| Index of drugs |
|
1731 | (49) |
| Index of Side Effects |
|
1780 | |
Shopping Cart
